Search

Author/Creator Soto Parra, Hector

1. Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer. Issue 1 (21st November 2019)

Authors:
Landi, Lorenza; D'Incà, Federica; Gelibter, Alain; Chiari, Rita; Grossi, Francesco; Delmonte, Angelo; Passaro, Antonio; Signorelli, Diego; Gelsomino, Francesco; Galetta, Domenico; Giannarelli, Diana; Soto Parra, Hector; Minuti, Gabriele; Tiseo, Marcello; Migliorino, Maria Rita; Cognetti, Francesc...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Ceritinib compassionate use for patients with crizotinib-refractory, anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer. (February 2018)

Authors:
Metro, Giulio; Passaro, Antonio; Lo Russo, Giuseppe; Bonanno, Laura; Giusti, Raffaele; Gregorc, Vanesa; Capelletto, Enrica; Martelli, Olga; Cecere, Fabiana L; Giannarelli, Diana; Luciani, Andrea; Bearz, Alessandra; Tuzi, Alessandro; Scotti, Vieri; Tonini, Giuseppe; Galetta, Domenico; Carta, Annam...
Journal:
Future oncology
Issue:
Volume 14:Number 4(2018)
Page Start:
353
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial. Issue 10 (October 2021)

Authors:
Pinto, Carmine; Zucali, Paolo Andrea; Pagano, Maria; Grosso, Federica; Pasello, Giulia; Garassino, Marina Chiara; Tiseo, Marcello; Soto Parra, Hector; Grossi, Francesco; Cappuzzo, Federico; de Marinis, Filippo; Pedrazzoli, Paolo; Bonomi, Maria; Gianoncelli, Letizia; Perrino, Matteo; Santoro, Arma...
Journal:
Lancet oncology
Issue:
Volume 22:Issue 10(2021)
Page Start:
1438
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients. (April 2019)

Authors:
Passiglia, Francesco; Galvano, Antonio; Castiglia, Marta; Incorvaia, Lorena; Calò, Valentina; Listì, Angela; Mazzarisi, Salvatore; Perez, Alessandro; Gallina, Giuseppe; Rizzo, Sergio; Soto Parra, Hector; Bazan, Viviana; Russo, Antonio
Journal:
Therapeutic advances in medical oncology
Issue:
Volume 11(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗